Position in ELAN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$283,905
+$7,842 QoQ
Shares Held
11,864
-2.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STEPHENS INC /AR/ holds $14,914,083 across 7 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
108,583 | $12,835,596 | |
| 2 | HLN |
Haleon plc
|
93,085 | $931,780 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,803 | $355,506 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
2,356 | $310,379 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
11,864 | $283,905 | |
| 6 | VTRS |
Viatris Inc
|
13,870 | $187,383 | |
| 7 | CGC |
Canopy Growth Corp
|
10,047 | $9,534 |
All Filings in ELAN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $283,905 | 11,864 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $276,063 | 12,199 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $261,658 | 12,992 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $163,406 | 11,443 | Shares | Defined | 2025-07-29 | |
| 2021-09-30 | $209,517 | 6,570 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $230,896 | 6,656 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||